Page last updated: 2024-10-29

iotrolan and Abnormalities, Autosome

iotrolan has been researched along with Abnormalities, Autosome in 1 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Significantly elevated frequencies of chromosomal abnormalities caused by postirradiation treatment with hypertonic contrast agents appeared to increase with increasing hypertonicity."1.30The effect of iodine-based contrast agents on the levels of radiation-induced chromosomal aberrations. ( Iwasawa, T; Kong, ZS; Kubota, N; Kurihara, H; Matsubara, S; Omura, M; Torigoe, S; Yoshida, T, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsubara, S1
Kong, ZS1
Omura, M1
Kurihara, H1
Torigoe, S1
Iwasawa, T1
Yoshida, T1
Kubota, N1

Other Studies

1 other study available for iotrolan and Abnormalities, Autosome

ArticleYear
The effect of iodine-based contrast agents on the levels of radiation-induced chromosomal aberrations.
    Radiation research, 1997, Volume: 147, Issue:2

    Topics: Adult; Cells, Cultured; Chromosome Aberrations; Chromosomes, Human; Contrast Media; Diatrizoate; DNA

1997